- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Grassley to NIH: Crack the Whip
20 November 2008 2:14 pm
Expect no letup in the investigation of U.S. biomedical researchers who violate conflict-of-interest regulations. So says Senator Chuck Grassley (R–IA), who’s been hammering scientists who receive pay from drug companies but fail to comply with U.S. rules requiring them to report such outside income. In a conversation on 19 November, Grassley told Science that the National Institutes of Health (NIH) needs to be more aggressive about getting the universities and researchers it funds to disclose consulting income. The Iowa lawmaker is concerned that NIH's plan to revise the reporting rules is an excuse for inaction. That could take a couple of years, Grassley says. "They can change [the rules] if they want to, but ... they've got plenty of leverage with just yanking back grants," he says.
One institution has already suffered that fate—Emory University in Atlanta, which had an NIH grant suspended after Grassley’s inquiry identified a psychiatry department chair who had allegedly not properly reported some income. Grassley staffers say that some universities—such as Stanford in Palo Alto, California—have told investigators that they have seen no significant lapses. But a Harvard University inquiry is “ongoing,” Senate aides say—and likely to make news again.